NCT04353648

Assessing Muscle Metabolic Phenotype by MSK Ultrasound

Name: Clinical Trial NCT04353648
Creator: Duke University
Keywords: Ultrasound, clinical trial, United States of America

Assessment of Muscle Metabolic Phenotype by the Use of Point-of-care MSK Ultrasound Imaging.

Duke University·ClinicalTrials.govSuspended

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Ultrasound
Study type: Observational

Sponsor & location

Primary sponsor: Duke University
Location: Durham, United States of America

Timeline & enrollment

Phase: N/A
Start date: Nov 01, 2019
End date: Oct 01, 2022
Enrollment: 200 participants

Primary outcome

Muscle Quality from the rectus femoris, vastus lateralis, intermedius, intercostalis, temporalis and styloglossus,Muscle volume and thickness from the rectus femoris, vastus lateralis, intermedius, intercostalis, temporalis and styloglossus

Summary

The purpose of this study is to test whether ultrasound images (pictures) can be used as a valid assessment of muscle quality in different muscle groups during Intensive Care stay. This new approach would allow clinicians to obtain frequent skeletal muscle images and would enable doctors to observe any changes over time in muscle quality that could occur during ICU stay.  Participants in this study will have ultrasound images made of their leg-, chest- and jaw muscles taken on every day until ICU discharge.

ICD-10 classifications

Abnormal ultrasonic finding on antenatal screening of motherAntenatal screening for malformations using ultrasound and other physical methodsAntenatal screening for fetal growth retardation using ultrasound and other physical methodsOther diagnostic agentsExamination of ears and hearing

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT04353648
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT04353648 through Pure Global AI's free database. This phase not specified trial is sponsored by Duke University and is currently Suspended. The study focuses on Ultrasound. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.